Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results

Gayoso, JorgeBalsalobre, PascualKwon, MiCastilla-Llorente, CristinaJesus Pascual, MariaLopez-Corral, LuciaLuis Pinana, JoseBermudez, AranchaAntonio Perez-Simon, JoseHerrera, PilarMontesinos, PauFerra, ChristelleSampol Mayol, AntoniaAnguita, JavierHeras, InmaculadaChamp, DianaMartinez-Laperche, CarolinaSolano, CarlosCaballero, DoloresLuis Diez-Martin, Jose2024-07-042024-07-042015-02Gayoso J, Balsalobre P, Kwon M, Castilla-Llorente C, Jesus Pascual M, Lopez-Corral L, et al. Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results [meeting abstract]. Biol Blood Marrow Transplant. 2015 Feb;21(Suppl 2):S284.1083-8791http://hdl.handle.net/20.500.13003/17322http://hdl.handle.net/20.500.12105/20098BMT Tandem Meetings. San Diego, CA. FEB 11-15, 2015.enghttp://creativecommons.org/licenses/by-nc-nd/4.0/Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Resultsconference presentationAttribution-NonCommercial-NoDerivatives 4.0 International212 (S1)S284-S28410.1016/j.bbmt.2014.11.4501523-6536Biology of Blood and Marrow Transplantationopen access348633000406